Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03519295
Title A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma (SCARCE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group

anal squamous cell carcinoma


Cisplatin + Docetaxel + Fluorouracil

Atezolizumab + Cisplatin + Docetaxel + Fluorouracil

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.